Tylosin Tartrate 20% Injectionsolution for Parenteral Use

Name: Tylosin Tartrate 20% Injectionsolution for Parenteral Use
Brand: Hebei Guangren Pharmaceutical Technology Co., Ltd.
SKU: 1950529882

Hebei, ChinaHebei Guangren Pharmaceutical Technology Co., Ltd.

US$1.90

5,000 bottle

Sample price:US$2.00/bottle.Request sample

Product profile

Customization

Available

Varieties

Infectious Disease Prevention Medicine

Component

Chemical Synthetic Drugs

Model NO.

2022050601

Type

The First Class

Pharmacodynamic Influential Factors

Repeated Medication

Storage Method

Light Proof

Veterinary Reg. No.

01256

Transport Package

100ml/Bottle

Specification

20% or customized

Trademark

GRDR

Origin

China

HS Code

294190

Production Capacity

50000bottles/Day

Company profile

Hebei Guangren Pharmaceutical Technology Co., Ltd.

Hebei, China

Business Type: Manufacturer/FactoryExport Year: 2011-05-11Nearest Port: XINGANG QINGDAOAverage Response Time: ≤15hTerms of Payment: LC, T/T, PayPal, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF

AI-Powered supplier vetting

SummaryHebei Guangren Pharmaceutical Technology Co., Ltd., based in Shijiazhuang, Hebei, China, is a private-owned trade company that also functions as a manufacturer. The company specializes in the production of over 300 veterinary drugs and has a strong emphasis on R&D and quality control. It holds certifications like BSCI, ISO 9000, and GMP, indicating compliance with international management standards. With a significant portion of its sales being exports, the company has a wide international market presence. Its production capability is robust, with five production lines and a substantial annual output.

Supplier typeThe supplier is a private owner, categorized as both a trade company and a manufacturer, specializing in veterinary drugs.

CertificationsThe supplier holds BSCI, ISO 9000, and GMP certifications, indicating compliance with international standards for management and production.

R&D capabilityThe company invests heavily in R&D, resulting in strong product update capabilities and a scientific R&D system.

Production capacityThe supplier operates five production lines, with an annual output of 500 million boxes of veterinary medicine, indicating strong production capability.

Send Inquiry

*To:

Hebei Guangren Pharmaceutical Technology Co., Ltd.

*Content:

0/4000

Supplier replies will be sent to your registered email

Tylosin Tartrate 20% Injectionsolution for Parenteral Use